Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.

Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Felker GM, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, She L, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F, VICTOR Study Group.

Open source

DOI: 10.1016/s0140-6736(25)01665-4
Published: 2025-08-30
Container: Lancet
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-01665-4,
  title = {Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.},
  author = {Butler J and  McMullan CJ and  Anstrom KJ and  Barash I and  Bonaca MP and  Borentain M and  Corda S and  Ezekowitz JA and  Felker GM and  Gates D and  Lam CSP and  Lewis EF and  Lindenfeld J and  Mentz RJ and  O'Connor CM and  Ponikowski P and  Reddy YNV and  Rosano GMC and  Saldarriaga C and  Senni M and  She L and  Teixeira PP and  Udelson J and  Urbinati A and  Vlajnic V and  Voors AA and  Xing A and  Patel MJ and  Zannad F and  VICTOR Study Group.},
  year = {2025},
  journal = {Lancet},
  doi = {10.1016/s0140-6736(25)01665-4},
  url = {https://doi.org/10.1016/s0140-6736(25)01665-4}
}

RIS

TY  - JOUR
TI  - Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
AU  - Butler J
AU  -  McMullan CJ
AU  -  Anstrom KJ
AU  -  Barash I
AU  -  Bonaca MP
AU  -  Borentain M
AU  -  Corda S
AU  -  Ezekowitz JA
AU  -  Felker GM
AU  -  Gates D
AU  -  Lam CSP
AU  -  Lewis EF
AU  -  Lindenfeld J
AU  -  Mentz RJ
AU  -  O'Connor CM
AU  -  Ponikowski P
AU  -  Reddy YNV
AU  -  Rosano GMC
AU  -  Saldarriaga C
AU  -  Senni M
AU  -  She L
AU  -  Teixeira PP
AU  -  Udelson J
AU  -  Urbinati A
AU  -  Vlajnic V
AU  -  Voors AA
AU  -  Xing A
AU  -  Patel MJ
AU  -  Zannad F
AU  -  VICTOR Study Group.
PY  - 2025
JO  - Lancet
DO  - 10.1016/s0140-6736(25)01665-4
UR  - https://doi.org/10.1016/s0140-6736(25)01665-4
ER  -

APA

J, B., CJ, M., KJ, A., I, B., MP, B., M, B., S, C., JA, E., GM, F., D, G., CSP, L., EF, L., J, L., RJ, M., CM, O., P, P., YNV, R., GMC, R., C, S., M, S., L, S., PP, T., J, U., A, U., V, V., AA, V., A, X., MJ, P., F, Z., & Group., V. S. (2025). Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet. https://doi.org/10.1016/s0140-6736(25)01665-4

Source records

europe-pmc · retrieved 2026-09-25T13:17:10.331Z